LAI FUNG HOLD (01125) Announces Annual Results: Net Loss Attributable to Owners Approximately HK$592 Million, Up 41.1% Year-on-Year
LAI FUNG HOLD (01125) announced its annual results for the year ended July 31, 2026: turnover of approximately HK$1.508 billion, up 16.8% year-on-year; net loss attributable to owners of the Company of approximately HK$592 million, up 41.1% year-on-year.
LAI FUNG HOLD (01125) announced its annual results for the year ended July 31, 2026, with revenue of approximately HK$1.508 billion, up 16.8% year-on-year; net loss attributable to owners of the company was approximately HK$592 million, up 41.1% year-on-year.
The announcement stated that the loss was mainly due to the loss arising from the sale of a residential building (T1) of Hengqin Innovation Square Phase 2 and the write-down of properties of Hengqin Innovation Square Phase 2 (mainly T3) during the review year.
Related Articles
CMSC: Financial Street Holdings Forum Annual Meeting Convened; U.S. Intensifies Mediation Efforts Between Russia and Ukraine
From Metaverse to Muse: Bernstein Says Meta (META.US) Bull Case "Fully Returns," Muse Poised to Unlock "Endless" Growth Opportunities
MEGA GENOMICS (06667) repurchased 90,000 shares for HK$638,300 on October 20.
CMSC: Financial Street Holdings Forum Annual Meeting Convened; U.S. Intensifies Mediation Efforts Between Russia and Ukraine
From Metaverse to Muse: Bernstein Says Meta (META.US) Bull Case "Fully Returns," Muse Poised to Unlock "Endless" Growth Opportunities
MEGA GENOMICS (06667) repurchased 90,000 shares for HK$638,300 on October 20.
